Norcliffe Capital

Norcliffe Capital is a London-based UK venture capital firm investing directly in early-stage medical technology and biotechnology companies. It focuses on disruptive MedTech and BioTech businesses with strong IP, unmet medical needs, and management teams positioned for investment and exit within 4-7 years. The firm backs HealthTech, Medical Devices, Biotechnology, Life Sciences and Impact opportunities in the United Kingdom and can support up to four projects a year.